Abbott made one of the biggest deals in recent medtech history last week when it announced its plan to acquire Exact Sciences — maker of colon cancer screening test Cologuard — for $23 billion.

Master the art of 2D and 3D kinematics using vectors! This video breaks down key concepts like displacement, velocity, and acceleration in multi-dimensional motion, with step-by-step vector analysis ...

In January, a team led by Jim Schuck, professor of mechanical engineering at Columbia Engineering, developed a method for creating entangled photon pairs, a critical component of emerging quantum ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Alex de Vigan, CEO at Nfinite, building large-scale 3D visual datasets to train Physical AI for retail, e-commerce & real-world AI. Enterprises have spent the last decade racing to catch up with cloud ...

North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

The cancer diagnostics specialist might, just might, be on the verge of selling itself. The apparent would-be buyer is a top name in the U.S. pharmaceutical industry. A strategic investor is ...

Nov 19 (Reuters) - Medical device maker Abbott Laboratories (ABT.N), opens new tab is nearing a potential takeover of cancer test maker Exact Sciences Corp (EXAS.O), opens new tab, Bloomberg News ...

Abbott Laboratories is nearing a potential acquisition of cancer screening company Exact Sciences Corp., people familiar with the matter said, in what could be the biggest deal of the year in the ...

EXCLUSIVE: Professor Hannah Fry and Vsauce creator Michael Stevens are teaming to host the latest podcast in Goalhanger‘s Rest is… franchise. Launching in a week’s time on November 25, video-first ...